A Study on Disease Awareness and Treatment Compliance of Heart Failure Patients

NCT05180396 | Completed

• 1 other identifier: K-J020
• Study Type: observational
• Target: 200
• Locations: 1 country
• Sites: 3

Brief Summary

The AWARENESS HF-PD is a cross-sectional, multicenter, survey-based study. Cases who were admitted to the outpatient clinic and hospitalized with the diagnosis of Heart Failure (Acute and Chronic) will be included in the study.

Conditions

Heart Failure

Keywords

Heart Failure; Questionnaire; ECHO; Prospective

Outcome Measures

Primary Outcomes (2)

• Demographics

  At the end of the six-month recruitment period, demographic, symptoms, clinical follow-up status, d will be performed on all included patients.

  6 months

• Disease Information

  At the end of the six-month recruitment period disease information, treatment compliance, and awareness assessment will be performed on all included patients.

  6 months

Secondary Outcomes (5)

• HF Risk Factors (BMI, Diabetes, Hypertension, HLP, Tobbaco Use, CV Hereditary, Menapause, MI History and History of CMP in family)

  6 months

• HF Percutaneous Intervention / Operation History (CRT, ICD, CRT-DI, Pacemaker, PKG, CABG and Heart Valve Operations)

  6 months

• HF Comorbidities (CAD, AF, COPD, CRF, Anemia, Iron Defficiency, Hypo- Hypertiroidy, OSAS)

  6 months

• HF Laboratory Results (Glucose, BUN, Creatinine, GFR, Sodium, Potassium, Nt-ProBNP, ALT, AST, ALP, HS-CRP, cTN, Hemoglobine, WBC, Ferritine, TSAD, LDL, tryglyceride, ST3, GGT, INR, ST4)

  6 months

• HF ECHO Results (EF, LA, SID, Mitral Defficiency, SPAB, DID, Septum, SEG Muscle Weakness, Trial Defficiency)

  6 Months

Study Arms (1)

Cases with the diagnosis of Heart Failure (Acute and Chronic)

Application of a questionnaire consisting of different questions to patients.

Other: Questionnaires

Interventions

Questionnaires OTHER

Application of a study based questionnaire described in the protocol

Cases with the diagnosis of Heart Failure (Acute and Chronic)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Cases with the diagnosis of Heart Failure (Acute and Chronic) who were admitted to the outpatient clinic and hospitalized will be included in the study. It is planned to include 200 patients from 3 centers in this study.

You may qualify if:

• Male or female patients aged 18 and over
• Patients diagnosed with acute or chronic heart failure
• Patients who agreed to participate in the study

You may not qualify if:

• Patients who stated that they did not agree to participate in the study
• Patients who were not diagnosed with Heart Failure or whose diagnosis was changed or not confirmed during the index application
• Pregnancy

Sponsors & Collaborators

• AstraZeneca Turkey: lead
• Klinar CRO: collaborator

Study Sites (3)

Akdeniz University Medical Faculty

Antalya, Turkey (Türkiye)

Location

Kahramanmaraş Sütçü İmam University Medical Faculty

Kahramanmaraş, Turkey (Türkiye)

Location

Mersin University Medical Faculty

Mersin, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Heart Failure

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Heart Diseases; Cardiovascular Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 3, 2021
• First Posted: January 6, 2022
• Study Start: March 12, 2021
• Primary Completion: July 30, 2021
• Study Completion: September 10, 2021
• Last Updated: February 23, 2023

Record last verified: 2023-02

Data Sharing

• IPD Sharing: Will not share

Locations

TU (3)